Works matching IS 0012186X AND DT 2024 AND VI 67 AND IP 3

Results: 16

Up Front.

Published in:: Diabetologia, 2024, v. 67, n. 3, p. 405, doi. 10.1007/s00125-024-06088-6
Publication type:: Article

Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy.

Published in:

Diabetologia, 2024, v. 67, n. 3, p. 561, doi. 10.1007/s00125-023-06072-6

By:

Dhanapalaratnam, Roshan;
Issar, Tushar;
Lee, Alexandra T. K.;
Poynten, Ann M.;
Milner, Kerry-Lee;
Kwai, Natalie C. G.;
Krishnan, Arun V.

Publication type:

Article

NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function.

Published in:

Diabetologia, 2024, v. 67, n. 3, p. 547, doi. 10.1007/s00125-023-06071-7

By:

Baumel-Alterzon, Sharon;
Katz, Liora S.;
Lambertini, Luca;
Tse, Isabelle;
Heidery, Fatema;
Garcia-Ocaña, Adolfo;
Scott, Donald K.

Publication type:

Article

Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study.

Published in:

Diabetologia, 2024, v. 67, n. 3, p. 494, doi. 10.1007/s00125-023-06067-3

By:

Raubenheimer, Peter J.;
Skelton, Joanna;
Peya, Bukiwe;
Dave, Joel A.;
Levitt, Naomi S.

Publication type:

Article

Maternal and neonatal outcomes according to the timing of diagnosis of hyperglycaemia in pregnancy: a nationwide cross-sectional study of 695,912 deliveries in France in 2018.

Published in:

Diabetologia, 2024, v. 67, n. 3, p. 516, doi. 10.1007/s00125-023-06066-4

By:

Regnault, Nolwenn;
Lebreton, Elodie;
Tang, Luveon;
Fosse-Edorh, Sandrine;
Barry, Yaya;
Olié, Valérie;
Billionnet, Cécile;
Weill, Alain;
Vambergue, Anne;
Cosson, Emmanuel

Publication type:

Article

The impact of taxing sugar-sweetened beverages on diabetes: a critical review.

Published in:

Diabetologia, 2024, v. 67, n. 3, p. 420, doi. 10.1007/s00125-023-06064-6

By:

Peñalvo, José L.

Publication type:

Article

Type 2 diabetes and succinate: unmasking an age-old molecule.

Published in:

Diabetologia, 2024, v. 67, n. 3, p. 430, doi. 10.1007/s00125-023-06063-7

By:

Fernández-Veledo, Sonia;
Marsal-Beltran, Anna;
Vendrell, Joan

Publication type:

Article

Comments on the notion of false positivity in measurements of autoantibodies. Reply to Grill V, Sørgjerd E, Hals I, Carlsson S [letter].

Published in:

2024

By:

Thomas, Nicholas J.;
Jones, Angus G.

Publication type:

Letter

Comments on the notion of false positivity in measurements of autoantibodies.

Published in:

2024

By:

Grill, Valdemar;
Sørgjerd, Elin;
Hals, Ingrid;
Carlsson, Sofia

Publication type:

Letter

GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion.

Published in:

Diabetologia, 2024, v. 67, n. 3, p. 528, doi. 10.1007/s00125-023-06060-w

By:

Gandasi, Nikhil R.;
Gao, Rui;
Kothegala, Lakshmi;
Pearce, Abigail;
Santos, Cristiano;
Acreman, Samuel;
Basco, Davide;
Benrick, Anna;
Chibalina, Margarita V.;
Clark, Anne;
Guida, Claudia;
Harris, Matthew;
Johnson, Paul R. V.;
Knudsen, Jakob G.;
Ma, Jinfang;
Miranda, Caroline;
Shigeto, Makoto;
Tarasov, Andrei I.;
Yeung, Ho Yan;
Thorens, Bernard

Publication type:

Article

Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study.

Published in:

Diabetologia, 2024, v. 67, n. 3, p. 483, doi. 10.1007/s00125-023-06057-5

By:

Krishnan, Arunkumar;
Schneider, Carolin V.;
Hadi, Yousaf;
Mukherjee, Diptasree;
AlShehri, Bandar;
Alqahtani, Saleh A.

Publication type:

Article

MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial.

Published in:

Diabetologia, 2024, v. 67, n. 3, p. 506, doi. 10.1007/s00125-023-06056-6

By:

Heianza, Yoriko;
Zhou, Tao;
Wang, Xuan;
Furtado, Jeremy D.;
Appel, Lawrence J.;
Sacks, Frank M.;
Qi, Lu

Publication type:

Article

Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research.

Published in:

Diabetologia, 2024, v. 67, n. 3, p. 407, doi. 10.1007/s00125-023-06055-7

By:

Basset-Sagarminaga, Jeremy;
van de Weijer, Tineke;
Iozzo, Patricia;
Schrauwen, Patrick;
Schrauwen-Hinderling, Vera

Publication type:

Article

Dose–response effects on HbA<sub>1c</sub> and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial.

Published in:

Diabetologia, 2024, v. 67, n. 3, p. 470, doi. 10.1007/s00125-023-06053-9

By:

Blüher, Matthias;
Rosenstock, Julio;
Hoefler, Josef;
Manuel, Raymond;
Hennige, Anita M.

Publication type:

Article

Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review.

Published in:

Diabetologia, 2024, v. 67, n. 3, p. 443, doi. 10.1007/s00125-023-06052-w

By:

Ahmed, Rabeeyah;
de Souza, Russell J.;
Li, Vincent;
Banfield, Laura;
Anand, Sonia S.

Publication type:

Article

Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study.

Published in:

Diabetologia, 2024, v. 67, n. 3, p. 459, doi. 10.1007/s00125-023-06048-6

By:

Gregg, Edward W.;
Chen, Haiying;
Bancks, Michael P.;
Manalac, Raoul;
Maruthur, Nisa;
Munshi, Medha;
Wing, Rena

Publication type:

Article